Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jean-Baptiste Briere, Kevin Bowrin, Craig Coleman, Laurent Fauchier, Pierre Levy, Kerstin Folkerts, Mondher Toumi, Vanessa Taieb, Aurélie Millier & Olivia Wu. (2019) Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review. Expert Review of Pharmacoeconomics & Outcomes Research 19:1, pages 27-36.
Read now
Read now
Articles from other publishers (4)
Riina Vibo, Juhan-Mats Kuningas, Prinno Tsakuhhin & Janika Kõrv. (2022) Deceptive Adherence to Anticoagulation in Secondary Stroke Prevention. Stroke Research and Treatment 2022, pages 1-7.
Crossref
Crossref
Anna Zatloukalová, Miroslav Homza & Martina Kovalová. (2021) Compliance a kvalita života u pacientů s antikoagulační léčbou: první výsledky pilotní studie. Profese online 13:2, pages 36-45.
Crossref
Crossref
Marek Hozman & Pavel Osmančík. (2020) Percutaneous left atrial appendage closure. Vnitřní lékařství 66:6, pages e3-e9.
Crossref
Crossref
Simona Dvořáčková, Kateřina Ládová, Josef Malý, Jozef Kolář & Miroslav Penka. (2017) Medication adherence to non-vitamin K antagonist oral anticoagulants at non-valvular atrial fibrillation - the literature review. Vnitřní lékařství 63:10, pages 633-639.
Crossref
Crossref